We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Peripartum Hysterectomy Strongly Linked to Earlier Cesarean

By HospiMedica staff writers
Posted on 30 Jan 2008
A new study has found that past cesarean (c-section) delivery markedly increases the risk of peripartum hysterectomy, an operation typically performed for life-threatening obstetric hemorrhage.

Researchers from the University of Oxford (UK) conducted a population-based, case-control comparison of data involving 318 women who had a hysterectomy following childbirth and 614 matched women who did not. More...
The results of the study showed that the incidence of hysterectomy following childbirth was 4.1 cases per 10,000 births. Overall, prior c-section increased the odds of peripartum hysterectomy 3.52-fold. However, this risk changed depending on the number of prior c-sections. The study showed that a c-section in the current pregnancy raised the risk 7.13-fold. Women who had two or more previous deliveries had more than 18 times the risk. Other risk factors for peripartum hysterectomy included maternal age over 35 years, parity of three or greater, previous manual placental removal, twin pregnancy, and, the strongest of all, previous myomectomy, which increased the risk 14-fold. The researchers believe that a prior c-section may increase the risk of peripartum hysterectomy by causing the placenta to grow either too low or through the wall of the womb. The study was published in the January 2008 issue of Obstetrics and Gynecology.

"It is important that women who have had a previous cesarean delivery are assessed in the last third of pregnancy to determine whether the placenta has grown in an abnormal site,” said lead author Marian Knight, M.D. "This way, we can help to identify women who are at risk of severe bleeding so that measures can be taken to try to prevent it.”


Related Links:
University of Oxford

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.